Internal Medicine and Multi System Disease Process

ICD has traditionally grouped diseases by aetiology and by affected organ system. For ICD¬11 the creation of a new chapter for multisystem disorders has been proposed. The following text sets out the rationale for and the possible scope of a multisystem  disorders chapter.

 

The concept of multisystem disorders is not new, however the meaning of “multisystem” as used in the literature is largely implicit and rarely defined explicitly except for case definitions of the CDC, and a mention in Webster’s Medical Dictionary. There is an important group of significant disorders which have varied manifestations and can affect so many organs that it is not possible to tie them to a single predominant organ system. Examples include Systemic lupus erythematosus, Dermatopolymyositis, Behçet disease, Multiple Sclerosis, Parkinson ’s disease, Polyarteritis nodosa, Sarcoidosis, Wegener granulomatosis, Mitochondrial disorders, Heredofamilial and developmental disorders.

  • Systemic Lupus Erythematosus
  • Dermatopolymyositis
  • Behçet Disease
  • Multiple Sclerosis
  • Parkinson’s Disease
  • Polyarteritis Nodosa
  • Sarcoidosis
  • Wegener Granulomatosis
  • Mitochondrial Disorders
  • Heredofamilial and Developmental Disorders

Related Conference of Internal Medicine and Multi System Disease Process

March 20-21, 2019

International Conference on Molecular Pathology

Paris | France
April 22-23, 2019

16th Annual Conference on Laboratory Medicine & Pathology

Kuala Lumpur, Malaysia
May 9-10, 2019

17th European Pathology Congress

| Amsterdam, Netherlands
June 28-29, 2019

Breast Pathology 2019

Oslo, Norway
July 29-30, 2019

17th Asia Pacific Pathology Congress

Mercure Albert Park, Melbourne, Australia
November 19-20, 2019

2nd European Pathology and Infectious Disease Conference

Helsinki, Finland

Internal Medicine and Multi System Disease Process Conference Speakers